OPP002 📄 Overview A VR/AR or haptic-feedback enabled SaMD that delivers personalized behavioral interventions, education, and skill-building exercises for chronic disease self-management (e.g., medication adherence, dietary changes, exercise regimens) in an engaging, adaptive, and immersive environment. Key technologies: 👤 Target users: 👍 Benefits Improved medication and treatment adherence • Better disease outcomes and reduced complications • Increased patient literacy and self-efficacy • Reduced hospitalizations and emergency room visits • More engaging and accessible therapeutic experiences Use bullets or new lines. 👎 Challenges Cost and accessibility of hardware (VR/AR headsets) • Potential for motion sickness or discomfort with VR • Rigorously clinical validation of therapeutic efficacy • Data security for highly sensitive behavioral health data • Integration into existing care pathways and clinician buy-in • Ensuring equitable access and cultural sensitivity 📋 Regulatory & Validation Likely Class II SaMD, requiring substantial clinical evidence • Need for robust usability testing and human factors analysis • Compliance with medical device software standards (IEC 62304) • Considerations for prescription digital therapeutic (PDT) pathways